dr reddy's glp-1 drugs portfolio 2025 Indian drugmaker Laboratories opens new tab hopes to launch a generic version of Novo Nordisk's opens new tab blockbuster weight‑loss drug Wegovy at a competitive price that could be up Dr Reddy's Introduces OLYMVIQ for

Nrgaard CH, Friedrich S, Hansen CT, Gerds T, Ballard C, Mller DV, et al

Common side effects of the drug include nausea, vomiting, diarrhea, constipation and indigestion

Risk of aspiration pneumonitis after elective esophagogastroduodenoscopy in patients on glucagon-like peptide-1 receptor agonists

Following T-cell activation GLP-1R expression increased significantly, particularly in CD8 + T cells (85)

PATHOGENESIS OF MASLD/MASH The development and progression of MASLD/MASH involve intricate interconnections among multiple metabolic, inflammatory, and fibrogenic mechanisms [2,6,16]

Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies: a meta-analysis based on cardiovascular outcomes trials